Skip to content

Epidaurus · Treatment Guide · Therapeutic Interventions

Going abroad for —

Cancer Treatment Cost Savings

Oncology treatment cost savings including surgery, radiation, and systemic therapy

The country comparison

Which countries are best for cancer treatment cost savings

The destinations ranked high→low under this lens — each with the reasoning behind its score, the cited evidence one click down, and its full report. The verdict is free; the report is the depth.

19 / 19 Countries ranked

Researched and assessed by the Epidaurus editorial pipeline against our published scale. A country below the rule is not yet assessed enough — never ranked last.

  1. 1 India IN 5.0/5 Good India demonstrates exceptional cancer treatment cost savings of 65-90% compared to Western countries, with comprehensive treatment packages available at $3,000-$30,000. Multiple financing options exist including gover... Full report
    The evidence behind this score 5 cited points
    • 65-90% cost savings documented across cancer treatments vs US and UK
    • Comprehensive treatment packages available at $3,000-$30,000 for complete care
    • Multiple financing options: cash, cards, wire transfers, international insurance, government programs
    • Immunotherapy: 70-80% savings; CAR-T therapy: up to 90% savings compared to origin countries
    • Government initiatives including tax incentives, 200 cancer daycare centers, and streamlined medical visa processes

    Read the full India report →

  2. 2 Turkey TR 5.0/5 Good Turkey demonstrates exceptional cancer treatment cost savings of 50-80%, with immunotherapy reaching 80% savings compared to the US, comprehensive treatment packages available for $7,000-$20,000 (well under the $25,00... Full report
    The evidence behind this score 4 cited points
    • Cancer treatment costs 50-70% less than in the U.S. or Western Europe, with immunotherapy reaching up to 80% savings ($8,000-$12,000 in Turkey vs. $50,000-$70,000 in the US)
    • Comprehensive treatment packages available for major cancer types: breast cancer at €10,000, colorectal cancer at $5,182-$20,755, ovarian cancer at €10,000-€25,000
    • Multiple financing options including international insurance acceptance, installment payment plans from Turkish banks at reduced interest rates, and government support covering up to $1,000 per patient plus 50% of airline costs
    • 41 JCI-accredited clinics with transparent pricing and dedicated international patient services in multiple languages

    Read the full Turkey report →

  3. 3 Malaysia MY 4.5/5 Good Malaysia delivers 60-80% cost savings on major cancer treatments (surgery, chemotherapy, radiation), exceeding Score 4's 50-69% threshold and approaching Score 5's 70%+ target. Most comprehensive cancer packages are p... Full report
    The evidence behind this score 8 cited points
    • Cancer surgery cost savings: 60-70% (USD 2,000-11,000 vs USD 15,000-50,000+ in US)
    • Chemotherapy savings: 75-80% per cycle (USD 500-2,200 vs USD 5,000-11,000 in US)
    • Radiotherapy savings: 65-75% (USD 1,000-6,500 vs USD 10,000-30,000 in US)
    • Comprehensive treatment packages: breast cancer USD 7,500-28,000, prostate USD 12,000-35,000, lung from USD 16,000
    • World-class infrastructure: Sunway Medical Centre ESMO-designated, SJMC first ACHS Centre of Excellence for Oncology in Asia-Pacific
    • Advanced treatments: CAR-T USD 75,000-125,000 (40%+ savings vs Singapore), bone marrow transplant USD 27,000-33,000 (40%+ savings vs US)
    • Financing barrier: 100% upfront deposit required for surgical admissions, limited formal medical financing for international patients
    • Immunotherapy limitation: checkpoint inhibitors USD 66,000-133,000 with no government subsidies, not achieving 50%+ savings vs Western pricing

    Read the full Malaysia report →

  4. 4 South Korea KR 4.5/5 Good South Korea demonstrates exceptional cancer treatment cost savings of 40-70% compared to the US, UK, and Germany, with many major treatments showing 67-85% savings (e.g., robotic surgery at one-third USA cost, radiati... Full report
    The evidence behind this score 5 cited points
    • Medical tourists save 40-70% on treatments in Korea compared to the US, UK, or Germany
    • Monoclonal antibody therapy costing $150,000 in USA available for $30,000 in South Korea
    • Cancer treatment costs range from $7,000 to $30,000 for comprehensive care including treatment, accommodation, and transportation
    • Hospitals offer transparent pricing through Korean National Health Insurance Service (NHIS) data structures
    • Government actively supports medical tourism through the Act on Support for Overseas Expansion of Healthcare System, visa simplification, and regulation against overcharging

    Read the full South Korea report →

  5. 5 Hungary HU 4.0/5 Good Hungary offers documented 40–70% cost savings on major cancer treatments compared to high-cost origin countries, with comprehensive multimodal treatment packages (surgery, IMRT, chemotherapy) available for $12,000–$25... Full report
    The evidence behind this score 6 cited points
    • Cost savings 40–70% vs. UK/US/Nordic countries; specific examples show 80–90% (US $65,000–$150,000 vs. Hungary $12,000–$25,000 for multimodal treatment)
    • Complete multimodal cancer treatment packages (surgery + IMRT + chemotherapy) available for $12,000–$25,000 in Budapest
    • FirstMed Budapest accepts direct billing from 110+ international insurance partners including Bupa Global, Cigna, Aetna International; Medicover and Duna Medical accept major international plans
    • EU Cross-Border Healthcare Directive enables reimbursement up to home country tariff for EU/EEA patients; S2 form route provides direct billing
    • Pricing opacity is a significant structural problem; almost no oncology-specific pricing publicly available, forcing patients to request individual quotes
    • Advanced immunotherapy severely constrained: pembrolizumab covers only 38.5% of approved indications vs. EU average 59%; out-of-pocket cost ~€4,900/infusion with significant access gaps

    Read the full Hungary report →

  6. 6 Israel IL 4.0/5 Good Israel achieves 50-75% cost savings on major cancer treatments (chemotherapy, surgery, immunotherapy) compared to the U.S., UK, Canada, and Australia, meeting the 50-69% threshold for Score 4. Treatment packages for c... Full report
    The evidence behind this score 6 cited points
    • Major cancer surgery savings: 50-70% (Israel $23,000-$31,000 vs. U.S. $50,000-$100,000)
    • Chemotherapy: 50-75% savings ($2,000-$7,000 in Israel vs. $10,000-$20,000 in U.S.)
    • CAR-T therapy: ~75% savings ($90,000-$120,000 in Israel vs. $400,000-$700,000 in U.S.)
    • Common cancer packages: Breast $13,375-$18,000; lung $28,880; prostate $10,000-$60,000
    • Immunotherapy savings: up to 85% cheaper than U.S./UK
    • 20+ JCI-accredited hospitals with dedicated international patient departments and insurance coordination capability

    Read the full Israel report →

  7. 7 Jordan JO 4.0/5 Good Jordan demonstrates 50-69% cost savings on major cancer treatments, particularly surgical oncology and radiation therapy, with comprehensive breast cancer packages available at $8,404-13,518 versus $28,000-68,000+ in ... Full report
    The evidence behind this score 5 cited points
    • Mastectomy costs $24,000 in Jordan versus $40,000-70,000 in the US (40-65% savings); colorectal resection $31,000 versus $50,000-80,000 in the US
    • Breast cancer first-year treatment documented at $8,404-13,518 across stages versus $28,000-68,000+ in the US (50-80% savings)
    • Radiation therapy IMRT courses $16,000 versus $30,000-35,000+ in the US; bone marrow transplantation $25,000-40,000 versus $1,071,700 in the US
    • Advanced therapies (pembrolizumab $144,709/year, osimertinib 3-year course $259,431) show minimal discount from US rates due to global pharmaceutical pricing
    • KHCC Cancer Care Insurance open to all nationalities; major hospitals accept Cigna Global, Allianz Care, and AXA PPP direct billing

    Read the full Jordan report →

  8. 8 United Arab Emirates AE 4.0/5 Good The United Arab Emirates delivers 50-75% cost savings on major cancer treatments compared to the United States and 30-65% versus the United Kingdom, with breast cancer packages at USD 9,080-35,000 documented at accred... Full report
    The evidence behind this score 6 cited points
    • UAE cancer treatment costs USD 8,000-35,000 for breast cancer care versus US equivalent of USD 50,000-150,000+, representing 50-75% savings; vs. UK USD 20,000-100,000, representing 30-65% savings
    • Comprehensive breast cancer treatment packages at Burjeel Hospital Abu Dhabi priced USD 9,080-16,618; radiation therapy USD 10,000-36,790; chemotherapy per cycle USD 1,090-4,080
    • Direct billing arrangements established with major international insurers (Cigna International, BUPA International, Aetna International, AXA, Allianz); 12-month instalment plans available
    • Pricing transparency gap documented: UAE hospitals require direct inquiry for personalized cost estimates, unlike India or Turkey where comprehensive package pricing is publicly accessible on hospital websites
    • Government subsidy programs (Basmah in Dubai, Abu Dhabi presidential mandate) explicitly reserved for UAE residents and Emiratis; non-resident international tourists do not qualify
    • Currency advantage limited: UAE dirham pegged to USD (no advantage for US patients); moderate fluctuation benefits only for British, Australian, Canadian, European patients

    Read the full United Arab Emirates report →

  9. 9 Colombia CO 4.0/5 Good Colombia delivers 50–70% cost savings on major cancer treatments, with comprehensive packages available at $10,000–$30,000 versus U.S. costs of $80,000–$200,000+. Multiple international insurers (Cigna Global, Bupa, A... Full report
    The evidence behind this score 7 cited points
    • Comprehensive cancer packages (surgery + chemotherapy + radiation + follow-up) cost $10,000–$30,000 in Colombia versus $80,000–$200,000+ in the US (50–90% savings for surgical cases)
    • Major surgery savings: mastectomy with reconstruction $2,500–$5,000 in Colombia versus $15,000–$55,000 in the US (60–90% savings)
    • Radiation therapy full courses $6,000–$10,000 in Colombia versus $17,000–$25,000 in the US (40–60% savings)
    • Six JCI-accredited hospitals accept direct billing from major international insurers (Cigna Global, Bupa, AXA, Allianz) and international patient departments with English-speaking coordinators
    • No formal government subsidies or tax incentives for international cancer patients, unlike competing destinations (Thailand, Turkey)
    • Fee-for-service billing structure complicates transparent total-cost estimation; hidden costs can add 20–40% to quoted prices
    • Immunotherapy (pembrolizumab, nivolumab) remains expensive at $50,000–$120,000 per year self-pay; drug-intensive regimens generate only 30–50% savings, limiting advanced-therapy cost advantage

    Read the full Colombia report →

  10. 10 Germany DE 4.0/5 Good Germany demonstrates 45-80% cost savings on major cancer treatments versus the USA, with treatment packages for common cancers ranging €14,000-€85,000, and transparent G-DRG pricing that applies equally to all patient... Full report
    The evidence behind this score 6 cited points
    • Major cancer surgery 45-65% cheaper than USA (€25,000-€45,000 vs €65,000-€85,000)
    • Chemotherapy up to 80% savings over USA ($1,200-$5,000 vs $13,000 average)
    • Treatment packages: prostate €14,000-€38,000; colorectal €18,000-€48,000; breast €45,000-€85,000
    • G-DRG regulated pricing with legally mandated transparent cost estimates; no foreigner markup
    • International insurance accepted (Cigna, Allianz); facilitator insurance up to €200,000 for complications
    • Advanced treatments: HIPEC 40-50% cheaper than USA; Lu-177 PSMA €12,700-€28,900; proton therapy €15,000-€35,000

    Read the full Germany report →

  11. 11 Spain ES 4.0/5 Good Spain achieves 40–70% cost savings on major cancer treatments compared to high-cost origin countries (US, UK, Canada, Australia), meeting the Score 4 threshold of 50–69%. Comprehensive treatment packages for common ca... Full report
    The evidence behind this score 5 cited points
    • ISPOR Europe 2024 study documents median 62% discount on branded oncology drugs in Spain vs. US (oral targeted agents 73%, biologics 59%)
    • Advanced breast cancer treatment: 60–80% savings ($25,000–$60,000 in Spain vs. $150,000–$200,000 in US)
    • Hospital Ruber Internacional comprehensive oncology package: $13,170 including consultations, medications, and follow-up blood work
    • Early-stage cancer packages widely available under $40,000 (breast cancer $5,000–$15,000, early colorectal from $18,000)
    • International health insurance (Allianz, AXA, Cigna Global, Bupa) operates in Spain with direct billing at major private hospitals; however, pricing is not transparently published and requires direct inquiry

    Read the full Spain report →

  12. 12 Mexico MX 4.0/5 Good Mexico demonstrates strong cost competitiveness with 50-70% savings on major cancer treatments compared to high-cost origin countries, comprehensive treatment packages under $40,000, transparent pricing, and flexible ... Full report
    The evidence behind this score 7 cited points
    • 50-70% cost savings on major cancer treatments compared to US, UK, Canada, Australia
    • Comprehensive cancer treatment packages available at $5,000-$30,000 for complete care
    • Chemotherapy at 71% savings ($1,500-$4,000 per session vs $13,000 in US)
    • Transparent upfront pricing with all-inclusive packages covering consultations, diagnostics, treatment, accommodation, and meals
    • Installment payment plans available, though most U.S. insurance does not cover international treatment
    • Favorable currency exchange rate providing additional savings for international patients
    • Advanced facilities with JCI accreditation providing quality care at reduced costs

    Read the full Mexico report →

  13. 13 Thailand TH 4.0/5 Good Thailand demonstrates strong cost savings of 50-70% on major cancer treatments compared to high-cost origin countries (US, UK, Australia), with extensive financing options and insurance acceptance at 60+ JCI-accredite... Full report
    The evidence behind this score 5 cited points
    • 60-70% cost savings on cancer treatments compared to US/UK/Australia; patients save 50-70% average
    • Chemotherapy costs $2,000-$5,000 (73% savings vs $13,000 US); radiation $5,500-$10,000 (74% savings vs $30,000 US)
    • Multiple financing options with insurance acceptance at leading hospitals; government CIT incentives for cancer centers
    • 60+ Joint Commission International-accredited hospitals; Bumrungrad's advanced oncology center treating 18,000+ patients annually
    • Immunotherapy available at $20,000-$40,000 (33% less than US costs); comprehensive treatment packages 2-3× lower than separate procedure costs

    Read the full Thailand report →

  14. 14 Poland PL 3.5/5 Moderate Poland demonstrates 50-70% cost savings on major surgical oncology procedures (mastectomy at USD 2,905 vs USD 30,000-50,000 in the US), meeting the lower threshold for Score 4. Some financing options and insurance acc... Full report
    The evidence behind this score 5 cited points
    • 50-70% cost savings on major surgical oncology procedures compared to Western Europe and US, with mastectomy documented at USD 2,905 versus USD 30,000-50,000 in the US
    • Comprehensive surgical-focused packages available in USD 2,900-77,900 range depending on procedure complexity and treatment modalities
    • Pricing transparency issues identified: majority of Polish oncology centres display 'price upon request' rather than published rates, complicating pre-trip budgeting
    • Pharmaceutical pricing paradox: Poland recorded among the highest per-unit prices for key oncology medicines relative to national income, with drug costs that 'could partially cancel out procedural savings' for immunotherapy and targeted therapy patients
    • Limited financing for international patients: LM PAY installment plans available but 'primarily target Polish residents'; international patients typically pay via wire transfer or credit card

    Read the full Poland report →

  15. 15 Brazil BR 3.5/5 Moderate Brazil offers strong value for surgical oncology and standard chemotherapy patients from high-income countries (40–60% savings vs. US, packages under $40,000), with broad insurance acceptance and favorable currency ex... Full report
    The evidence behind this score 6 cited points
    • 40–60% cost savings on surgical oncology and standard chemotherapy documented vs. US; specific examples include mastectomy with reconstruction at $15,000–$35,000 vs. $60,000–$120,000 in US, and FOLFOX chemotherapy at $2,000–$12,000 vs. $30,000–$60,000 in US
    • BRL depreciation of 21.5% in 2024 (5.39 to 6.18 BRL/USD) provides significant additional currency advantage for USD-holding patients
    • Pembrolizumab and nivolumab are 225% and 362% more expensive respectively than in Canada and New Zealand, eliminating cost advantage for immunotherapy-dependent advanced cancer patients
    • Pricing transparency is limited; hospitals operate on quote-upon-inquiry model with no public price lists, and cost estimates vary by surgeon grade and room category
    • Top hospitals accept 60+ international insurance plans with direct-billing arrangements, partially offsetting lack of government subsidies and formal financing for international patients
    • No proton therapy available in Brazil or anywhere in Latin America; stereotactic body radiotherapy available in only 16% of Brazilian radiation departments, limiting access to advanced modalities

    Read the full Brazil report →

  16. 16 Singapore SG 3.0/5 Moderate Singapore offers moderate cost savings of 25–40% on most major cancer treatments versus high-cost countries like the US, with particular strength in radiation therapy (50–65% savings) and surgical oncology. However, c... Full report
    The evidence behind this score 5 cited points
    • Overall cost savings of 25–40% versus high-cost countries (US, UK, Canada, Australia), with radiation therapy offering 50–65% specific savings
    • 18-month comprehensive cancer treatment costs ranging $70,000–$200,000 (lung cancer $199,500, breast cancer $134,500) exceed $50,000 threshold
    • Immunotherapy costs $113,000–$170,000 annually, comparable to Western markets with 0% savings; CAR-T therapy ~$475,000, also comparable globally
    • Strong international insurance acceptance (BUPA, Cigna, Aetna, Allianz, AXA) with direct-billing arrangements, but no government subsidies or incentive programs for international patients
    • Transparent pricing through bill estimators and dedicated international coordinators, but pricing is primarily fee-for-service rather than all-inclusive packages

    Read the full Singapore report →

  17. 17 Japan JP 2.5/5 Moderate Japan offers exceptional particle radiotherapy savings (70-80% vs US) but this represents a specialized niche within oncology. For the broader cancer treatment landscape, Japan lacks comprehensive packages, financing ... Full report
    The evidence behind this score 5 cited points
    • Particle therapy savings of 70-80% ($27,000-$33,000 for carbon-ion vs US $100,000-$150,000) represents world-leading value for this modality only
    • Japan's anticancer drug prices are the highest in East Asia ($50,859 median), with 3× international patient multiplier approaching or matching US self-pay costs
    • Explicit red flags: no comprehensive treatment packages, no financing options, no government subsidies, cash-only prepayment requirement with no discounts
    • Integrated treatment scenario (surgery + chemotherapy + particle therapy + accommodation) totals $124,000-$191,000—not dramatically cheaper than US integrated care
    • Report concludes patients seeking standard oncology care would find significantly lower costs in India, Thailand, or South Korea

    Read the full Japan report →

  18. 18 United Kingdom GB 1.0/5 Poor The United Kingdom is among the world's most expensive destinations for cancer treatment, not a cost-savings destination. UK private cancer costs are 3-5× higher than India, 70-85% more expensive than Turkey and Thail... Full report
    The evidence behind this score 6 cited points
    • UK breast cancer treatment costs USD $20,000–$100,000 vs Thailand's $7,500–$23,000 (2.7-13× more expensive)
    • UK mastectomy £9,000–£18,000 vs India's equivalent $4,500–$6,000 (3-5× higher cost)
    • UK immunotherapy for lung cancer $60,000–$100,000 vs Turkey $2,200–$5,400 representing up to 85% cost disadvantage for UK
    • Pricing transparency is a significant barrier with most major UK private cancer centres not publishing costs online; requires individual inquiry
    • No government subsidies, medical tourism incentives, or state-funded pathways for international cancer patients
    • No meaningful consumer financing products available; advance payment required for self-pay international patients

    Read the full United Kingdom report →

  19. 19 United States US 1.0/5 Poor The United States is the world's highest-cost environment for cancer treatment, with costs 50-80% higher than international medical tourism alternatives. There are no comprehensive treatment packages available for int... Full report
    The evidence behind this score 5 cited points
    • Cancer treatment costs in the US are 50-80% higher than medical tourism destinations like India, Mexico, Thailand, and Turkey
    • Immunotherapy costs exceed $100,000 per patient, with some therapies reaching $850,000 including medical support
    • Monthly chemotherapy costs range from $1,000-$12,000; Americans travel abroad because treatment costs $4,000 in Mexico versus $12,000 in the US
    • No comprehensive cancer treatment packages exist for international patients; US facilities offer complex fee-for-service pricing only
    • Extreme pricing opacity and variation: identical chemotherapy drug costs $134 at one clinic and $13,560 at another, with hospitals marking up drugs 2.5-3 times acquisition cost, reaching 350 times higher in extreme cases

    Read the full United States report →

Reading the field

What separates a good programme from a dangerous one

Every country above is graded against this published scale — the same 1–5 rubric for cancer treatment cost savings, top to bottom. How we score →

  1. 5/5 Excellent

    - 70%+ cost savings available on major cancer treatments compared to high-cost origin countries (US, UK, Canada, Australia) - Comprehensive treatment packages available for all major cancer types under $25,000 for complete care - Multiple financing options, insurance acceptance, and government incentives for international patients - Transparent, competitive pricing with detailed cost breakdowns readily available - Strong currency advantages providing additional savings for multiple nationalities - Premium treatments (immunotherapy, targeted therapy) available at 50%+ savings compared to origin countries

  2. 4/5 Good

    - 50-69% cost savings on major cancer treatments compared to high-cost origin countries - Treatment packages available for common cancers under $40,000 for complete care - Some financing options and insurance arrangements available - Generally transparent pricing with cost information accessible through major facilities - Moderate currency advantages for international patients - Advanced treatments available at 30-49% savings compared to origin countries

  3. 3/5 Moderate

    - 30-49% cost savings on cancer treatments compared to high-cost origin countries - Basic treatment packages available but may exceed $50,000 for comprehensive care - Limited financing options, primarily cash-pay arrangements - Pricing information available but may require direct inquiry - Some cost advantages depending on currency fluctuations - Advanced treatments available but savings limited to 15-29% compared to origin countries

  4. 2/5 Poor

    - 15-29% cost savings on cancer treatments, minimal financial advantage - Few comprehensive packages, mostly fee-for-service pricing exceeding home country costs for some treatments - Very limited financing options or insurance acceptance - Pricing information difficult to obtain or unclear - Currency disadvantages may offset treatment savings - Advanced treatments expensive with minimal savings compared to origin countries

  5. 1/5 Very Poor / Unavailable

    - Less than 15% cost savings or costs equal to/exceeding home country prices - No comprehensive treatment packages, prohibitively expensive individual services - No financing options, cash-only payments required - Pricing information unavailable or inconsistent - Significant currency disadvantages increasing total costs - Limited treatment options with costs higher than origin countries

The reports

The full country reports under this lens

Each destination we have assessed has a full, cited report — the detailed analysis behind its score. The verdict is free; the report is the depth.

Clinics & providers

The clinics our research names

Named hospitals, clinics and centres cited across these findings — each carrying the specialties our reports record. Follow one to the reports behind it.

References

The sources behind these assessments

The distinct sources cited across these published reports — every finding carries its own citations; this is the union, each linking back to the reports that lean on it.

  1. Untitled source accessiblemeds.org/resources/blog/cancer-costs-and-options-care-united-states Cited in Cancer Treatment Cost Savings in United States
  2. Untitled source alliancecancercare.com/news/cost-of-radiation-treatment Cited in Cancer Treatment Cost Savings in United States
  3. Untitled source amedical.az/en/blogs/news/proton-therapy-cost Cited in Cancer Treatment Cost Savings in South Korea
  4. Untitled source ascopubs.org/doi/abs/10.1200/jop.2015.005694 Cited in Cancer Treatment Cost Savings in United States
  5. Untitled source bi-maristan.com/en/articles/chemotherapy-cost-turkey Cited in Cancer Treatment Cost Savings in Turkey
  6. Untitled source bi-maristan.com/en/articles/radiation-therapy-cost-turkey Cited in Cancer Treatment Cost Savings in Turkey
  7. Untitled source bi-maristan.com/en/radiology Cited in Cancer Treatment Cost Savings in Turkey
  8. Untitled source bioinformant.com/ways-to-curb-the-sky-high-costs-of-car-t-cell-therapy Cited in Cancer Treatment Cost Savings in South Korea
  9. Untitled source bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-021-10642-x Cited in Cancer Treatment Cost Savings in South Korea
  10. Untitled source cancercaree.com/cost-comparison Cited in Cancer Treatment Cost Savings in South Korea
  11. Untitled source cancercareglobal.com/best-hospitals-for-leukemia-treatment-in-mexico Cited in Cancer Treatment Cost Savings in Mexico
  12. Untitled source cancerrounds.com/costs/cancer-treatment-cost-india Cited in Cancer Treatment Cost Savings in India
  13. Untitled source cancerworld.net/patients-in-turkey-sue-reimbursement-price-cancer-drugs Cited in Cancer Treatment Cost Savings in Turkey
  14. Untitled source careerhospital.in/blog/cancer-treatment-cost-in-india Cited in Cancer Treatment Cost Savings in India
  15. Untitled source clinicsoncall.com/en/blog/cancer-treatment-in-turkey-hospitals-and-prices Cited in Cancer Treatment Cost Savings in Turkey
  16. Untitled source clinicsoncall.com/en/blog/is-turkey-the-right-choice-for-your-cancer-treatment-heres-what-you-should-know Cited in Cancer Treatment Cost Savings in Turkey
  17. Untitled source clinicsoncall.com/en/clinics/country-south-korea/oncology Cited in Cancer Treatment Cost Savings in South Korea
  18. Untitled source clinicsoncall.com/en/clinics/country-south-korea/oncology/procedure-brachytherapy Cited in Cancer Treatment Cost Savings in South Korea
  19. Untitled source clinicsoncall.com/en/clinics/country-turkey/oncology/procedure-immunotherapy Cited in Cancer Treatment Cost Savings in Turkey
  20. Untitled source curevalue.org/content/how-to-save-on-cancer-care-by-seeking-treatment-abroad Cited in Cancer Treatment Cost Savings in Turkey
  21. Untitled source doinasia.com/thailand-medical-tourism-strategies Cited in Cancer Treatment Cost Savings in Thailand
  22. Untitled source drhikmetihsaneren.com/en/the-easiest-ways-to-pay-for-surgery-in-turkey Cited in Cancer Treatment Cost Savings in Turkey
  23. Untitled source elclinics.com/news/science/best-countries-for-affordable-cancer-treatment Cited in Cancer Treatment Cost Savings in Turkey
  24. Untitled source elclinics.com/news/science/cancer-treatment-cost-compared-by-country Cited in Cancer Treatment Cost Savings in Thailand, Cancer Treatment Cost Savings in Turkey, Cancer Treatment Cost Savings in Mexico, Cancer Treatment Cost Savings in South Korea

Explore the source archive →

In plain language

Start exploring the knowledge base

The field's shorthand our reports use, sized by how often it comes up. Follow any term to its full entry and the reports that use it.

For readers weighing this decision

Ways to read the evidence

The verdict is always free. A membership opens the full analysis and every cited source — this specialty, the whole library, or everything for good.

  • One specialty · annual

    Therapeutic Interventions

    $49.00 / year

    $49.00/year

    Every report in this specialty — full analysis and every cited source — as each is published.

    Take this specialty

  • Full library · annual

    The whole library

    $199.00 / year

    $199.00/year

    The complete evidence behind every finding in every specialty, while your decision is live.

    Take the full library
  • Most readers

    Lifetime · one payment

    Everything, for good

    $499.00 once

    $499.00 (one-time)

    Every finding we publish today and hereafter — no renewal, no expiry. The tier we point most readers to.

    Take lifetime access

Prefer to pay per report? A single report is $29.00, yours to keep — browse the reports. The verdict is always free.

Where to go from here · Cancer Treatment Cost Savings

no scope is a dead end — step up to the specialty, drill into a factor, or pivot across to a country or a comparison